491 related articles for article (PubMed ID: 12724631)
21. Recent advances in the localization and surgical management of duodenal gastrinomas.
Lawton GP; Modlin IM
Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
[TBL] [Abstract][Full Text] [Related]
22. Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognostic factors and surgical procedure?
Robin L; Sauvanet A; Walter T; Najah H; Falconi M; Pattou F; Gaujoux S;
Surgery; 2023 May; 173(5):1144-1152. PubMed ID: 36781315
[TBL] [Abstract][Full Text] [Related]
23. Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma.
Bartsch DK; Waldmann J; Fendrich V; Boninsegna L; Lopez CL; Partelli S; Falconi M
Br J Surg; 2012 Sep; 99(9):1234-40. PubMed ID: 22864882
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of sporadic gastrinoma.
Lorenz K; Dralle H
Wien Klin Wochenschr; 2007; 119(19-20):597-601. PubMed ID: 17985095
[TBL] [Abstract][Full Text] [Related]
25. Gastrinoma: advances in localization and treatment.
Norton JA
Surg Oncol Clin N Am; 1998 Oct; 7(4):845-61. PubMed ID: 9735137
[TBL] [Abstract][Full Text] [Related]
26. Outcome of surgical treatment for extrapancreatic gastrinomas.
Chiarugi M; Pucciarelli M; Goletti O; Buccianti P; Cavina E
Surg Gynecol Obstet; 1993 Aug; 177(2):153-7. PubMed ID: 8342095
[TBL] [Abstract][Full Text] [Related]
27. A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas.
Matsubayashi H; Kawata N; Kakushima N; Tanaka M; Takizawa K; Kiyozumi Y; Horiuchi Y; Sasaki K; Sugiura T; Uesaka K; Ono H
BMC Gastroenterol; 2017 Mar; 17(1):37. PubMed ID: 28270118
[TBL] [Abstract][Full Text] [Related]
28. Localization, malignant potential, and surgical management of gastrinomas.
Kisker O; Bastian D; Bartsch D; Nies C; Rothmund M
World J Surg; 1998 Jul; 22(7):651-7; discussion 657-8. PubMed ID: 9606277
[TBL] [Abstract][Full Text] [Related]
29. Duodenal gastrinoma: the solution to the pancreatic paradox.
Modlin IM; Lawton GP
J Clin Gastroenterol; 1994 Oct; 19(3):184-8. PubMed ID: 7806825
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.
Gibril F; Venzon DJ; Ojeaburu JV; Bashir S; Jensen RT
J Clin Endocrinol Metab; 2001 Nov; 86(11):5282-93. PubMed ID: 11701693
[TBL] [Abstract][Full Text] [Related]
31. Surgery to cure the Zollinger-Ellison syndrome.
Norton JA; Fraker DL; Alexander HR; Venzon DJ; Doppman JL; Serrano J; Goebel SU; Peghini PL; Roy PK; Gibril F; Jensen RT
N Engl J Med; 1999 Aug; 341(9):635-44. PubMed ID: 10460814
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment and prognosis of gastrinoma.
Norton JA
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):799-805. PubMed ID: 16253901
[TBL] [Abstract][Full Text] [Related]
34. [Zollinger-Ellison syndrome].
Fendrich V; Bartsch DK; Langer P; Zielke A; Rothmund M
Chirurg; 2005 Mar; 76(3):217-26. PubMed ID: 15688179
[TBL] [Abstract][Full Text] [Related]
35. Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.
Thom AK; Norton JA; Doppman JL; Miller DL; Chang R; Jensen RT
Surgery; 1992 Dec; 112(6):1002-8; discussion 1008-9. PubMed ID: 1455303
[TBL] [Abstract][Full Text] [Related]
37. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
[TBL] [Abstract][Full Text] [Related]
38. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
39. Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1.
Bartsch DK; Langer P; Rothmund M
Wien Klin Wochenschr; 2007; 119(19-20):602-8. PubMed ID: 17985096
[TBL] [Abstract][Full Text] [Related]
40. [Management of gastrinoma].
Hain E; Coriat R; Dousset B; Gaujoux S
Presse Med; 2016 Nov; 45(11):986-991. PubMed ID: 27262229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
